XML 16 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities:    
Net loss $ (17,127,000) $ (15,981,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 794,000 761,000
Amortization of deferred financing costs and debt discount 714,000 714,000
Joint Venture acquisition obligation accretion 24,000 340,000
Provision for expired inventory 26,000 0
Change in fair value of warrants 0 (4,988,000)
Stock-based compensation expense 925,000 1,617,000
Loss on asset disposal 2,000 5,000
Loss on debt extinguishment 0 260,000
Increases (decreases) in cash caused by changes in operating assets and liabilities:    
Accounts receivable 91,000 131,000
Inventories 190,000 (10,000)
Other current assets 205,000 (258,000)
Other assets 32,000 762,000
Accounts payable and accrued expenses (1,013,000) 870,000
Deferred revenues (8,000) 41,000
Long-term deferred rent (227,000) (210,000)
Net cash used in operating activities (15,372,000) (15,946,000)
Cash flows from investing activities:    
Purchases of property and equipment (110,000) (544,000)
Expenditures for intellectual property 0 (13,000)
Net cash used in investing activities (110,000) (557,000)
Cash flows from financing activities:    
Principal payments on long-term obligations 0 (25,032,000)
Proceeds from long-term obligations 0 17,700,000
Debt issuance costs and loan fees 0 (1,854,000)
Joint Venture purchase payments (1,774,000) (1,623,000)
Proceeds from exercise of employee stock options and warrants 0 4,986,000
Proceeds from sale of common stock, net 17,702,000 26,749,000
Dividends paid on preferred stock 0 (75,000)
Net cash provided by financing activities 15,928,000 20,851,000
Effect of exchange rate changes on cash and cash equivalents 140,000 0
Net increase in cash and cash equivalents 586,000 4,348,000
Cash and cash equivalents at beginning of period 14,338,000 14,622,000
Cash and cash equivalents at end of period 14,924,000 18,970,000
Cash paid during period for:    
Interest 1,213,000 1,607,000
Supplemental schedule of non-cash investing and financing activities:    
Conversion of preferred stock into common stock 0 10,000
Declared dividend related to preferred stock $ 0 $ 3,000